American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: Editor-in-chief: Samy, I. McFarlane
Open Access
Journal Browser
American Journal of Medical Case Reports. 2015, 3(1), 18-19
DOI: 10.12691/ajmcr-3-1-7
Open AccessCase Report

Topical Heparin Therapy in Stasis Ul cer: A Case Report

Özlem Keskin1, , Ahmet Karagöz2, Kadir Öymen Hançerlioğulları3, Alptekin Tosun4 and İlker İlhanlı5

1Department of Cardiovascular surgery, Giresun University, Giresun, Turkey,

2Department of Cardiology, Giresun University, Giresun, Turkey

3Department of Pediatric Surgery, Giresun University, Giresun, Turkey

4Department of Radiology, Giresun University, Giresun, Turkey

5Department of Physical Therapy and Rehabilitation, Giresun University, Giresun, Turkey

Pub. Date: January 13, 2015

Cite this paper:
Özlem Keskin, Ahmet Karagöz, Kadir Öymen Hançerlioğulları, Alptekin Tosun and İlker İlhanlı. Topical Heparin Therapy in Stasis Ul cer: A Case Report. American Journal of Medical Case Reports. 2015; 3(1):18-19. doi: 10.12691/ajmcr-3-1-7


Venous leg ulcers are the late and severe clinical form of chronic venous disease. Superficial venous system, deep venous system or perforating veins between them which are affected by reflux, obstruction or inability of the muscle pump, play an important role in pathophysiology. Compression bandages and wound care are the basis of treatment for venous ulcers. For ulcers which do not respond to these treatments, surgical procedures may be considered. There is a need for a multidisciplinary approach for the treatment and follow-up of venous leg ulcers. Cutaneous lesions like stasis ulcer are common in patients with chronic renal failure. Healing of chronic ulcer is difficult and can take time. Here we emphasized the effects of topical use of un-fractionated heparin on wound healing of an elderly male patient with chronic renal failure.

stasis ulcer chronic renal failure heparin

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Saliba MJ Jr. The effects and uses of heparin in the care of burns that improves treatment and enhances the quality of life. Acta Chir Plast. 1997; 39: 13-6.
[2]  Agbenorku P, Fugar S, Akpaloo J, Hoyte-Williams PE, Alhassan Z, Agyei F. Management of severe burn injuries with topical heparin: the first evidence-based study in Ghana. Int J Burns Trauma. 2013; 3(1): 30-6. Epub 2013 Jan 24.
[3]  De Cock R, Ficker LA, Dart JG, Garner A, Wright P. Topical heparin in the treatment of ligneous conjunctivitis. Ophthalmology. 1995 Nov; 102(11): 1654-9.
[4]  Hiebert LM, Lui JM. Heparin protects cultured arterial endothelial cells from damage by toxic oxygen metabolites. Arteriosclerosis. 1990; 83: 37-51.
[5]  Kritikos O, Tsagarakis M, Tsoutsos D, Kittas C, Gorgoulis V, Papalois A et al. O. The efficacy of recombinant human activated protein C (rhAPC) vs antithrombin III (at III) vs heparin, in the healing process of partial-thickness burns: a comparative study. Ann Burns Fire Disasters. 2012 Jun 30; 25(2): 66-73.